close
close Close

Latest on Twitter

Smart Branding
menu
Click Therapeutics
Click Therapeutics raised $52 million in a Series B funding round

Click Therapeutics is a regulated Software as a Medical Device (SaMD)-focused biotechnology company. They raised a total of $911 million.

Previous page Next page